Author
Listed:
- Ton J. Cleophas
(European Interuniversity College of Pharmaceutical Medicine Lyon
Albert Schweitzer Hospital, Department Medicine)
- Aeilko H. Zwinderman
(European Interuniversity College of Pharmaceutical Medicine Lyon
Academic Medical Center Amsterdam, Department Biostatistics and Epidemiology)
- Toine F. Cleophas
(Technical University)
Abstract
Summary Background: The crossover design is a sensitive means of determining the efficacy of new drugs because it eliminates between subject-variability. However, when the response in the first period carries on into the second (carryover effects) or when time factors can not be kept constant in a lengthy crossover (time effects), the statistical power of testing may be jeopardized. We recently demonstrated that the crossover design with binary variables is a powerful method in spite of such factors as carryover effects. Power analysis of crossover trials with continuous variables have not been explicitly studied. Objective: Using the Grizzle model for the assessment of treatment effect, carryover effect and time effect, we drew power curves of hypothesized crossover studies with different levels of correlation between drug reponse. Results: We demonstrate that the sensitivity of testing is largely dependent on the levels of correlation between drug response. Whenever the correlation coefficient is >0, we soon will have better sensitivity to test treatment effect than carryover effect or time effect of similar size. Whenever levels of correlation are not strong positive or negative the statistical power to demonstrate similarly-sized treatment and carryover effect, or treatment and time effect is approximately 80%, which is an acceptable level for reliable testing. Conclusions: The crossover design is a powerful method for assessing positively correlated treatment comparisons, despite the risk of carryover and time effects.
Suggested Citation
Ton J. Cleophas & Aeilko H. Zwinderman & Toine F. Cleophas, 2002.
"Crossover Studies with Continuous Variables: Power Analysis,"
Springer Books, in: Statistics Applied to Clinical Trials, edition 0, chapter 0, pages 133-142,
Springer.
Handle:
RePEc:spr:sprchp:978-94-010-0337-7_12
DOI: 10.1007/978-94-010-0337-7_12
Download full text from publisher
To our knowledge, this item is not available for
download. To find whether it is available, there are three
options:
1. Check below whether another version of this item is available online.
2. Check on the provider's
web page
whether it is in fact available.
3. Perform a
for a similarly titled item that would be
available.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:sprchp:978-94-010-0337-7_12. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.